Top advances of the year: Neoadjuvant immunotherapy in melanoma

被引：0
作者：
Chen, Monica F. [1 ,2 ]
Postow, Michael A. [1 ,2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Med Oncol, New York, NY USA
[2] Weill Cornell Med Ctr, New York, NY USA
来源：
CANCER | 2025年 / 131卷 / 09期
关键词：
immunotherapy; melanoma; neoadjuvant;
D O I：
10.1002/cncr.35877
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：6
相关论文
共 21 条
  • [1] [Anonymous], 2025, Bristol Myers Squibb Provides Update on Phase 3 RELATIVITY098 Trial
  • [2] [Anonymous], 2024, Press Release
  • [3] Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma
    Blank, Christian U.
    Lucas, Minke W.
    Scolyer, Richard A.
    van de Wiel, Bart A.
    Menzies, Alexander M.
    Lopez-Yurda, Marta
    Hoeijmakers, Lotte L.
    Saw, Robyn P. M.
    Lijnsvelt, Judith M.
    Maher, Nigel G.
    Pulleman, Saskia M.
    Gonzalez, Maria
    Acosta, Alejandro Torres
    van Houdt, Winan J.
    Lo, Serigne N.
    Kuijpers, Anke M. J.
    Spillane, Andrew
    Klop, W. Martin C.
    Pennington, Thomas E.
    Zuur, Charlotte L.
    Shannon, Kerwin F.
    Seinstra, Beatrijs A.
    Rawson, Robert V.
    Haanen, John B. A. G.
    Ch'ng, Sydney
    Naipal, Kishan A. T.
    Stretch, Jonathan
    van Thienen, Johannes V.
    Rtshiladze, Michael A.
    Wilgenhof, Sofie
    Kapoor, Rony
    Meerveld-Eggink, Aafke
    Grijpink-Ongering, Lindsay G.
    van Akkooi, Alexander C. J.
    Reijers, Irene L. M.
    Gyorki, David E.
    Gruenhagen, Dirk J.
    Speetjens, Frank M.
    Vliek, Sonja B.
    Placzke, Joanna
    Spain, Lavinia
    Stassen, Robert C.
    Amini-Adle, Mona
    Lebbe, Celeste
    Faries, Mark B.
    Robert, Caroline
    Ascierto, Paolo A.
    van Rijn, Rozemarijn
    van den Berkmortel, Franchette W. P. J.
    Piersma, Djura
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2024,
  • [4] Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapy
    Chan, Wei Yen
    Lee, Jenny H.
    Stewart, Ashleigh
    Diefenbach, Russell J.
    Gonzalez, Maria
    Menzies, Alexander M.
    Blank, Christian
    Scolyer, Richard A.
    Long, Georgina V.
    Rizos, Helen
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)
  • [5] Early Readout on Overall Survival of Patients With Melanoma Treated With Immunotherapy Using a Novel Imaging Analysis
    Dercle, Laurent
    Zhao, Binsheng
    Gonen, Mithat
    Moskowitz, Chaya S.
    Firas, Ahmed
    Beylergil, Volkan
    Connors, Dana E.
    Yang, Hao
    Lu, Lin
    Fojo, Tito
    Carvajal, Richard
    Karovic, Sanja
    Maitland, Michael L.
    Goldmacher, Gregory, V
    Oxnard, Geoffrey R.
    Postow, Michael A.
    Schwartz, Lawrence H.
    [J]. JAMA ONCOLOGY, 2022, 8 (03) : 385 - 392
  • [6] COLUMBUS 5-Year Update: A Randomized, Open-Label, Phase III Trial of Encorafenib Plus Binimetinib Versus Vemurafenib or Encorafenib in Patients With BRAF V600-Mutant Melanoma
    Dummer, Reinhard
    Flaherty, Keith T.
    Robert, Caroline
    Arance, Ana
    de Groot, Jan Willem B.
    Garbe, Claus
    Gogas, Helen J.
    Gutzmer, Ralf
    Krajsova, Ivana
    Liszkay, Gabriella
    Loquai, Carmen
    Mandala, Mario
    Schadendorf, Dirk
    Yamazaki, Naoya
    di Pietro, Alessandra
    Cantey-Kiser, Jean
    Edwards, Michelle
    Ascierto, Paolo A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (36) : 4178 - +
  • [7] Seven-year analysis of adjuvant pembrolizumab versus placebo in stage III melanoma in the EORTC1325 / KEYNOTE-054 trial
    Eggermont, Alexander M. M.
    Kicinski, Michal
    Blank, Christian U.
    Mandala, Mario
    V. Long, Georgina
    Atkinson, Victoria
    Dalle, Stephane
    Haydon, Andrew
    Meshcheryakov, Andrey
    Khattak, Adnan
    Carlino, Matteo S.
    Sandhu, Shahneen
    Larkin, James
    Puig, Susana
    Ascierto, Paolo A.
    Rutkowski, Piotr
    Schadendorf, Dirk
    Boers-Sonderen, Marye
    Di Giacomo, Anna Maria
    van den Eertwegh, Alfonsus J. M.
    Grob, Jean-Jacques
    Gutzmer, Ralf
    Jamal, Rahima
    van Akkooi, Alexander C. J.
    Lorigan, Paul
    Grebennik, Dmitri
    Kreplere, Clemens
    Marreaud, Sandrine
    Suciu, Stefan
    Robert, Caroline
    [J]. EUROPEAN JOURNAL OF CANCER, 2024, 211
  • [8] A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma
    Huang, Alexander C.
    Orlowski, Robert J.
    Xu, Xiaowei
    Mick, Rosemarie
    George, Sangeeth M.
    Yan, Patrick K.
    Manne, Sasikanth
    Kraya, Adam A.
    Wubbenhorst, Bradley
    Dorfman, Liza
    D'Andrea, Kurt
    Wenz, Brandon M.
    Liu, Shujing
    Chilukuri, Lakshmi
    Kozlov, Andrew
    Carberry, Mary
    Giles, Lydia
    Kier, Melanie W.
    Quagliarello, Felix
    McGettigan, Suzanne
    Kreider, Kristin
    Annamalai, Lakshmanan
    Zhao, Qing
    Mogg, Robin
    Xu, Wei
    Blumenschein, Wendy M.
    Yearley, Jennifer H.
    Linette, Gerald P.
    Amaravadi, Ravi K.
    Schuchter, Lynn M.
    Herati, Ramin S.
    Bengsch, Bertram
    Nathanson, Katherine L.
    Farwell, Michael D.
    Karakousis, Giorgos C.
    Wherry, E. John
    Mitchell, Tara C.
    [J]. NATURE MEDICINE, 2019, 25 (03) : 454 - +
  • [9] Predicting pathological complete response to neoadjuvant chemoimmunotherapy in resected NSCLC with radiomic signatures
    Khorrami, M.
    Mutha, P. J.
    Delasos, L.
    Nikoo, M. Zokaei
    Pennell, N. A.
    Madabhushi, A.
    [J]. ANNALS OF ONCOLOGY, 2024, 35 : S785 - S786
  • [10] KEYMAKER-U02 substudy 02C: Neoadjuvant pembrolizumab (pembro) and investigational agents followed by adjuvant pembro for stage IIIB-D melanoma
    Long, G. V.
    Robert, C.
    Hill, A. G.
    Marqueste, C. Gaudy
    Portnoy, D.
    Shapira, R.
    Cohen, J. E.
    Khattak, M. A.
    Lebbe, C.
    Menzies, A. M.
    Markel, G.
    Bar-Sela, G.
    Sharfman, W. H.
    Pages, C.
    Hamid, O.
    Mehnert, J. M.
    Jing, N.
    Kalabis, M.
    Krepler, C.
    Dummer, R.
    [J]. ANNALS OF ONCOLOGY, 2024, 35 : S712 - S713
123